Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review

Min Li,* Chenchen Wu,* Yan Liu, Ranran Zhang, Qingqing Yang, Zhaoming Shi, Weihua Sun, Xiaolei Hu Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People’s Republic of China*These authors contributed equally to this...

Full description

Bibliographic Details
Main Authors: Li M, Wu C, Liu Y, Zhang R, Yang Q, Shi Z, Sun W, Hu X
Format: Article
Language:English
Published: Dove Medical Press 2022-04-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/autoimmune-polyendocrinopathy-induced-by-an-antibody-kn046-that-simult-peer-reviewed-fulltext-article-DMSO
_version_ 1797716045196165120
author Li M
Wu C
Liu Y
Zhang R
Yang Q
Shi Z
Sun W
Hu X
author_facet Li M
Wu C
Liu Y
Zhang R
Yang Q
Shi Z
Sun W
Hu X
author_sort Li M
collection DOAJ
description Min Li,* Chenchen Wu,* Yan Liu, Ranran Zhang, Qingqing Yang, Zhaoming Shi, Weihua Sun, Xiaolei Hu Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaolei Hu, Department of endocrinology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, Anhui Province, 233000, People’s Republic of China, Tel +8613855216339, Email caesar80@163.comAbstract: Endocrine adverse reactions are one of the most common adverse reactions in the treatment of immune checkpoint inhibitors (ICIs), mainly involving the pituitary gland, pancreas, thyroid gland, adrenal gland and other glands, resulting in corresponding endocrine dysfunction. We report a 45-year-old man with non-small-cell lung cancer who developed hypophysitis 11 months after initiation of treatment with an anti-PD-L1/CTLA-4 bispecific antibody (KN046) that blocks both programmed death ligand-1 (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4), followed by regular oral replacement doses of prednisone and levothyroxine tablets. The patient was diagnosed with type 1 diabetes mellitus (T1DM) with diabetic ketoacidosis (DKA) 25 months after the start of immunotherapy, presenting with acute hyperglycemic symptoms, ketoacidosis, and negative diabetic autoantibodies. By describing a case of KN046 immunotherapy involving multiple endocrine glands and reviewing relevant literature, we were able to summarize the clinical characteristics of KN046 immunotherapy-induced endocrine system-related immune-related adverse events (irAEs) for use in early detection, diagnosis and treatment.Keywords: type 1 diabetes, immune checkpoint inhibitors, immune-related adverse reactions, KN046
first_indexed 2024-03-12T08:15:43Z
format Article
id doaj.art-526818f30cce4b5f92cd57a92fc6ae4f
institution Directory Open Access Journal
issn 1178-7007
language English
last_indexed 2024-03-12T08:15:43Z
publishDate 2022-04-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj.art-526818f30cce4b5f92cd57a92fc6ae4f2023-09-02T18:52:29ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072022-04-01Volume 151253126074729Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature ReviewLi MWu CLiu YZhang RYang QShi ZSun WHu XMin Li,* Chenchen Wu,* Yan Liu, Ranran Zhang, Qingqing Yang, Zhaoming Shi, Weihua Sun, Xiaolei Hu Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xiaolei Hu, Department of endocrinology, The First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, Anhui Province, 233000, People’s Republic of China, Tel +8613855216339, Email caesar80@163.comAbstract: Endocrine adverse reactions are one of the most common adverse reactions in the treatment of immune checkpoint inhibitors (ICIs), mainly involving the pituitary gland, pancreas, thyroid gland, adrenal gland and other glands, resulting in corresponding endocrine dysfunction. We report a 45-year-old man with non-small-cell lung cancer who developed hypophysitis 11 months after initiation of treatment with an anti-PD-L1/CTLA-4 bispecific antibody (KN046) that blocks both programmed death ligand-1 (PD-L1) and cytotoxic T-lymphocyte antigen-4 (CTLA-4), followed by regular oral replacement doses of prednisone and levothyroxine tablets. The patient was diagnosed with type 1 diabetes mellitus (T1DM) with diabetic ketoacidosis (DKA) 25 months after the start of immunotherapy, presenting with acute hyperglycemic symptoms, ketoacidosis, and negative diabetic autoantibodies. By describing a case of KN046 immunotherapy involving multiple endocrine glands and reviewing relevant literature, we were able to summarize the clinical characteristics of KN046 immunotherapy-induced endocrine system-related immune-related adverse events (irAEs) for use in early detection, diagnosis and treatment.Keywords: type 1 diabetes, immune checkpoint inhibitors, immune-related adverse reactions, KN046https://www.dovepress.com/autoimmune-polyendocrinopathy-induced-by-an-antibody-kn046-that-simult-peer-reviewed-fulltext-article-DMSOtype 1 diabetesimmune checkpoint inhibitorsimmune-related adverse reactionskn046
spellingShingle Li M
Wu C
Liu Y
Zhang R
Yang Q
Shi Z
Sun W
Hu X
Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
Diabetes, Metabolic Syndrome and Obesity
type 1 diabetes
immune checkpoint inhibitors
immune-related adverse reactions
kn046
title Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
title_full Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
title_fullStr Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
title_full_unstemmed Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
title_short Autoimmune Polyendocrinopathy Induced by an Antibody (KN046) That Simultaneously Inhibits PD-L1 and CTLA-4: A Case Report and Literature Review
title_sort autoimmune polyendocrinopathy induced by an antibody kn046 that simultaneously inhibits pd l1 and ctla 4 a case report and literature review
topic type 1 diabetes
immune checkpoint inhibitors
immune-related adverse reactions
kn046
url https://www.dovepress.com/autoimmune-polyendocrinopathy-induced-by-an-antibody-kn046-that-simult-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT lim autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT wuc autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT liuy autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT zhangr autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT yangq autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT shiz autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT sunw autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview
AT hux autoimmunepolyendocrinopathyinducedbyanantibodykn046thatsimultaneouslyinhibitspdl1andctla4acasereportandliteraturereview